Kalkine has a fully transformed New Avatar.
The company will deliver a bilingual digital platform for student assessments across Years 3 to 10 nationwide.
The company achieved its first full-yearpositive operating cash flowof AUD 1.9 million, a AUD 3.2 million turnaround from FY24.
The U.S. FDA raised no issues that could impact the planned Phase 2 trial, paving the way for an IND application in Q3 2025.
Highlights
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine! Start Your 7-Days Free Trial Today!
Continue
AU
CA
NZ
UK
US
IND
Please wait processing your request...